CHRONIC MYELOID LEUKEMIA (CML) PHILADELPHIA CHROMOSOME POSITIVE

Clinical trials for CHRONIC MYELOID LEUKEMIA (CML) PHILADELPHIA CHROMOSOME POSITIVE explained in plain language.

Never miss a new study

Get alerted when new CHRONIC MYELOID LEUKEMIA (CML) PHILADELPHIA CHROMOSOME POSITIVE trials appear

Sign up with your email to follow new studies for CHRONIC MYELOID LEUKEMIA (CML) PHILADELPHIA CHROMOSOME POSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet finished but already full! 1

New hope for CML patients: trial tests potential Game-Changer drug

Disease control Ongoing

This study is testing a new oral medication called asciminib against standard first-line treatments for adults newly diagnosed with a specific type of chronic myeloid leukemia (CML). The goal is to see if asciminib is more effective at controlling the disease and if patients can …

Matched conditions: CHRONIC MYELOID LEUKEMIA (CML) PHILADELPHIA CHROMOSOME POSITIVE

Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control

Last updated Mar 25, 2026 14:08 UTC

CHRONIC MYELOID LEUKEMIA (CML) PHILADELPHIA CHROMOSOME POSITIVE

Get alerted when new CHRONIC MYELOID LEUKEMIA (CML) PHILADELPHIA CHROMOSOME POSITIVE trials appear

New hope for CML patients: trial tests potential Game-Changer drug